High resolution MRI difference between moyamoya disease and intracranial atherosclerosis

European Journal of Neurology

Volumn 20, Issue 9, 2013, Pages 1311-1318

  Kim, Y J ^a   Lee, D H ^a   Kwon, J Y ^a   Kang, D W ^a   Suh, D C ^a   Kim, J S ^a   Kwon, S U ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

High resolution MRI; Intracranial atherosclerosis; Moyamoya disease

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; BRAIN ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; FEMALE; HUMAN; IMAGE QUALITY; INTRACRANIAL ATHEROSCLEROTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSION; PRIORITY JOURNAL; PROCEDURES;

HIGH RESOLUTION MRI; INTRACRANIAL ATHEROSCLEROSIS; MOYAMOYA DISEASE;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTRACRANIAL ARTERIOSCLEROSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOYAMOYA DISEASE;

EID: 84881011868     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12202     Document Type: Article

References (20)

1. Goto Y, Yonekawa Y. Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 1992; 32: 883-886.
2. Ikezaki K, Han DH, Kawano T, Inamura T, Fukui M. Epidemiological survey of moyamoya disease in Korea. Clin Neurol Neurosurg 1997; 99(Suppl 2): S6-S10.
3. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99(Suppl 2): S238-S240.
4. Saam T, Hatsukami TS, Takaya N, et al. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 2007; 244: 64-77.
5. Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002; 15: 62-67.
6. Li ML, Xu WH, Song L, et al. Atherosclerosis of middle cerebral artery: evaluation with high-resolution MR imaging at 3T. Atherosclerosis 2009; 204: 447-452.
7. Klein IF, Lavallee PC, Touboul PJ, Schouman-Claeys E, Amarenco P. In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology 2006; 67: 327-329.
8. Swartz RH, Bhuta SS, Farb RI, et al. Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology 2009; 72: 627-634.
9. Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005; 36: 782-786.
10. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-1375.
11. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431-1438.
12. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002; 105: 939-943.
13. Takagi Y, Kikuta K, Nozaki K, Hashimoto N. Histological features of middle cerebral arteries from patients treated for moyamoya disease. Neurol Med Chir (Tokyo) 2007; 47: 1-4.
14. Kaku Y, Morioka M, Ohmori Y, et al. Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) 2012; 154: 2151-2157.
15. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
16. Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke 1983; 14: 50-58.
17. Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR. Moyamoya disease: a summary. Neurosurg Focus 2009; 26: E11.
18. Chen JW, Wasserman BA. Vulnerable plaque imaging. Neuroimaging Clin N Am 2005; 15: 609-621, xi.
19. Vergouwen MD, Silver FL, Mandell DM, Mikulis DJ, Swartz RH. Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke. Arch Neurol 2011; 68: 338-342.
20. Ashley WW, Zipfel GJ, Moran CJ, Zheng J, Derdeyn CP. Moyamoya phenomenon secondary to intracranial atherosclerotic disease: diagnosis by 3T magnetic resonance imaging. J Neuroimaging 2009; 19: 381-384.